Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
TLDR
In the EU, the highest age-standardised incidence rates for oesophageal cancer are in the Netherlands for men and the UK for women, and variation between countries is high and may reflect different prevalence of risk factors, use of screening and diagnostic methods.About:
This article is published in Annals of Oncology.The article was published on 2013-10-01 and is currently open access. It has received 810 citations till now. The article focuses on the topics: European union & Cancer.read more
Citations
More filters
Journal ArticleDOI
Systematic review: the prevention of oesophageal stricture after endoscopic resection.
M Barret,B. Beye,S. Leblanc,Frédéric Beuvon,Stanislas Chaussade,Frédéric Batteux,Frédéric Prat +6 more
TL;DR: Extensive endoscopic resections for the treatment of early oesophageal neoplasia can result in fibro‐inflammatory strictures that require repeated interventions, which significantly alter the patients’ quality of life.
Journal ArticleDOI
Predictive Factors of Recurrence in Patients with Pathological Complete Response After Esophagectomy Following Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Study
Guillaume Luc,Caroline Gronnier,Gil Lebreton,Cécile Brigand,Jean-Yves Mabrut,Jean-Pierre Bail,Bernard Meunier,Denis Collet,Christophe Mariette +8 more
TL;DR: An intensive follow-up may be beneficial for patients with EC who achieve pCR and who develop major postoperative complications or the adenocarcinoma histologic subtype.
Journal ArticleDOI
International trends in oesophageal cancer survival by histological subtype between 1995 and 2014
Eileen Morgan,Isabelle Soerjomataram,Anna Gavin,Mark J. Rutherford,Piers A.C. Gatenby,Aude Bardot,Jacques Ferlay,Oliver Bucher,Prithwish De,Gerda Engholm,Christopher Jackson,Serena Kozie,Alana Little,Bjørn Møller,Lorraine Shack,Hanna E. Tervonen,Vicky Thursfield,Sally Vernon,Paul M. Walsh,Ryan Woods,Christian Finley,Neil D. Merrett,Dianne L. O'Connell,John V. Reynolds,Freddie Bray,Melina Arnold +25 more
TL;DR: Marked improvements in both oesophageal AC and SCC survival suggest advances in treatment, and the need for further advances in early detection and treatment of oesophileal cancer alongside primary prevention to reduce the overall burden from the disease.
Journal ArticleDOI
Preoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
Andrew Barbour,Andrew Barbour,E.T. Walpole,Gang Tao Mai,Elizabeth H Barnes,D.I. Watson,D.I. Watson,Stephen P. Ackland,Jarad Martin,M. Burge,M. Burge,R. Finch,Chris Karapetis,Chris Karapetis,J. Shannon,Louise M. Nott,Suresh C Varma,Gavin Marx,Gregory L. Falk,Val Gebski,M. Oostendorp,Kate Wilson,Janine Thomas,Guy Lampe,John Zalcberg,John Simes,Bernard Mark Smithers,Bernard Mark Smithers,A. Barbour,Euan Walpole,Tao Mai,David I. Watson,Christos S. Karapetis,L. Barnes +33 more
TL;DR: Early PET/CT has the potential to tailor therapy for patients not showing an early response to chemotherapy, and EMR is associated with favourable OS, PFS, and low LR.
Journal ArticleDOI
Parallel-Group Controlled Trial of Surgery Versus Chemoradiotherapy in Patients With Stage I Esophageal Squamous Cell Carcinoma
Ken Kato,Yoshinori Ito,Isao Nozaki,Hiroyuki Daiko,Takashi Kojima,Masahiko Yano,Masaki Ueno,Satoru Nakagawa,Masakazu Takagi,Shigeru Tsunoda,Tetsuya Abe,Tetsu Nakamura,Morihito Okada,Yasushi Toh,Yuichi Shibuya,Seiichiro Yamamoto,Hiroshi Katayama,Kenichi Nakamura,Yuko Kitagawa +18 more
TL;DR: In this paper, the authors investigated the noninferiority of chemoradiotherapy (CRT) relative to surgery for T1bN0M0 esophageal squamous cell carcinoma (ESCC) patients.
References
More filters
Book
AJCC Cancer Staging Manual
Mahul B. Amin,Stephen B. Edge,Frederick L. Greene,David R. Byrd,Robert K. Brookland,Mary Kay Washington,Jeffrey E. Gershenwald,Carolyn C. Compton,Kenneth R. Hess,Daniel C. Sullivan,J. Milburn Jessup,James D. Brierley,Lauri E. Gaspar,Richard L. Schilsky,Charles M. Balch,David P. Winchester,Elliot A. Asare,Martin Madera,Donna M. Gress,Laura R. Meyer +19 more
TL;DR: Purposes and Principles of Cancer Staging and End-Results Reporting are explained.
Journal ArticleDOI
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
David Cunningham,William H. Allum,Sally P. Stenning,Jeremy Thompson,Marianne Nicolson,J. Howard Scarffe,F. Lofts,Stephen Falk,Timothy Iveson,David Smith,Ruth E Langley,Monica Verma,Simon Weeden,Yu Jo Chua +13 more
TL;DR: In patients with operable gastric or lower esophageal adenocarcinomas, a perioperative regimen of ECF decreased tumor size and stage and significantly improved progression-free and overall survival.
Journal ArticleDOI
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
J. Ferlay,Eva Steliarova-Foucher,Joannie Lortet-Tieulent,Sonia Rosso,Jan Willem Coebergh,Harry Comber,David Forman,Freddie Bray +7 more
TL;DR: Up-to-date estimates of the cancer burden in Europe alongside the description of the varying distribution of common cancers at both the regional and country level provide a basis for establishing priorities to cancer control actions in Europe.
Journal ArticleDOI
Hospital Volume and Surgical Mortality in the United States
John D. Birkmeyer,Andrea E. Siewers,Emily Finlayson,Therese A. Stukel,F. Lee Lucas,Ida Batista,H. Gilbert Welch,David E. Wennberg +7 more
TL;DR: Mortality decreased as volume increased for all 14 types of procedures, but the relative importance of volume varied markedly according to the type of procedure.
Journal ArticleDOI
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
TL;DR: Preoperative chemoradiotherapy improved survival among patients with potentially curable esophageal or esophagogastric-junction cancer and the regimen was associated with acceptable adverse-event rates.
Related Papers (5)
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joel Shapiro,J. Jan B. van Lanschot,Maarten C.C.M. Hulshof,Pieter van Hagen,Mark I. van Berge Henegouwen,Bas P. L. Wijnhoven,Hanneke W. M. van Laarhoven,Grard A. P. Nieuwenhuijzen,Geke A. P. Hospers,Johannes J. Bonenkamp,Miguel A. Cuesta,Reinoud J. B. Blaisse,Olivier R. Busch,Fiebo J. W. ten Kate,Geert-Jan Creemers,Cornelis J. A. Punt,John T. M. Plukker,Henk M.W. Verheul,Ernst Jan Spillenaar Bilgen,Herman van Dekken,Maurice J.C. van der Sangen,Tom Rozema,Katharina Biermann,Jannet C. Beukema,Anna H.M. Piet,Caroline M. van Rij,Janny G. Reinders,Hugo W. Tilanus,Ewout W. Steyerberg,Ate van der Gaast +29 more